Company Filing History:
Years Active: 2025
Title: Claire Reader - Innovator in Antibody Molecules
Introduction
Claire Reader is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules that have potential applications in cancer treatment. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Claire Reader holds a patent for "Mesothelin and CD137 binding molecules." This invention relates to antibody molecules that bind both mesothelin (MSLN) and CD137. The antibody molecules comprise a CDR-based binding site for MSLN and a CD137 antigen-binding site located in a constant domain of the antibody molecule. This groundbreaking work has the potential to contribute significantly to cancer therapies.
Career Highlights
Throughout her career, Claire has worked with notable companies in the biotechnology sector, including Invox Pharma Limited and F-star Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and further her research endeavors.
Collaborations
Some of Claire's coworkers include Jose Munoz-Olaya and Mihriban Tuna. Their collaborative efforts have contributed to the advancement of innovative solutions in the biotechnology industry.
Conclusion
Claire Reader is a remarkable inventor whose work in antibody molecules is paving the way for new cancer treatments. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement.